Published on 6 Aug 2022 on Simply Wall St. via Yahoo Finance
What Kind Of Shareholders Hold The Majority In TCR2 Therapeutics Inc.'s (NASDAQ:TCRR) Shares?
The big shareholder groups in TCR2 Therapeutics Inc. (NASDAQ:TCRR) have power over the company. Institutions often own shares in more established companies, while it's not unusual to see insiders own a fair bit of smaller companies. We also tend to see lower insider ownership in companies that were previously publicly owned.
With a market capitalization of US$126m, TCR2 Therapeutics is a small cap stock, so it might not be well known by many institutional investors. Our analysis of the ownership of the company, below, shows that institutional investors have bought into the company. Let's delve deeper into each type of owner, to discover more about TCR2 Therapeutics.
See our latest analysis for TCR2 Therapeutics